Perjeta: Breast Cancer Drug Extends Overall Survival, Study Finds
Roche is also developing an "armed antibody" known as TDM-1 as a treatment for HER2-positive breast cancer. TDM-1 combines
perjeta breast cancer drug extend overall survival study find roche develop armed antibody know tdm treatment her positive breast cancer tdm combine